Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysisJennifer L. McQuade, Michael A. Davies, Daniel Wang et al.|The Lancet Oncology|2018Cited by 658
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y. Ng, Raphael Koch, Noriaki Yoshida et al.|Nature Communications|2018Cited by 114